This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sugita, T. Articles by Nishikawa, A. Search for Related Content PubMed PubMed Citation Articles by Sugita, T. Articles by Nishikawa, A.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, June 2005, p. 2824-2829, Vol. 43, No. 6
0095-1137/05/$08.00+0     doi:10.1128/JCM.43.6.2824-2829.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Antifungal Activities of Tacrolimus and Azole Agents against the Eleven Currently Accepted Malassezia Species

Takashi Sugita,^1* Mami Tajima,³ Tomonobu Ito,³ Masuyoshi Saito,³ Ryoji Tsuboi,³ and Akemi Nishikawa²

Department of Microbiology,¹ Department of Immunobiology, Meiji Pharmaceutical University, Kiyose, Tokyo, Japan,² Department of Dermatology, Tokyo Medical University, Shinjuku, Tokyo, Japan³

Received 4 September 2004/ Returned for modification 15 October 2004/ Accepted 7 February 2005

The lipophilic yeast Malassezia is an exacerbating factor in atopic dermatitis (AD) and colonizes the skin surface of patients with AD. With the goal of reducing the number of Malassezia cells, we investigated the antifungal activities of a therapeutic agent for AD, tacrolimus, and the azole agents itraconazole and ketoconazole against Malassezia species in vitro. We examined 125 strains of the 11 currently accepted Malassezia species by using the agar dilution method. All strains of the 11 Malassezia species were very susceptible to both azole agents, with MICs ranging from 0.016 to 0.25 µg/ml. Tacrolimus had antifungal activities against half of the strains, with MICs ranging from 16 to 32 µg/ml. Two of the major cutaneous floras, Malassezia globosa and Malassezia restricta, have several genotypes in the intergenic spacer region of the rRNA gene; the azole agents had slightly higher MICs for specific genotype strains of both microorganisms. A combination of azole agents and tacrolimus had a synergistic effect against Malassezia isolates, based on a fractional inhibitory index of 0.245 to 0.378. Our results provide the basis for testing these agents in future clinical trials to reduce the number of Malassezia cells colonizing the skin surface in patients with AD.

---

* Corresponding author. Mailing address: Department of Microbiology, Meiji Pharmaceutical University, 2-522-1 Noshio, Kiyose, Tokyo 204-8588, Japan. Phone: 81-424-95-8762. Fax: 81-424-95-8762. E-mail: sugita{at}my-pharm.ac.jp.

---

Journal of Clinical Microbiology, June 2005, p. 2824-2829, Vol. 43, No. 6
0095-1137/05/$08.00+0     doi:10.1128/JCM.43.6.2824-2829.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

This article has been cited by other articles:

• Dannaoui, E., Schwarz, P., Lortholary, O. (2009). In Vitro Interactions between Antifungals and Immunosuppressive Drugs against Zygomycetes. Antimicrob. Agents Chemother. 53: 3549-3551 [Abstract] [Full Text]  
• Selander, C., Engblom, C., Nilsson, G., Scheynius, A., Andersson, C. L. (2009). TLR2/MyD88-Dependent and -Independent Activation of Mast Cell IgE Responses by the Skin Commensal Yeast Malassezia sympodialis. J. Immunol. 182: 4208-4216 [Abstract] [Full Text]  
• Rincon, S., Cepero de Garcia, M. C., Espinel-Ingroff, A. (2006). A Modified Christensen's Urea and CLSI Broth Microdilution Method for Testing Susceptibilities of Six Malassezia Species to Voriconazole, Itraconazole, and Ketoconazole.. J. Clin. Microbiol. 44: 3429-3431 [Abstract] [Full Text]  
• Sugita, T., Tajima, M., Tsubuku, H., Tsuboi, R., Nishikawa, A. (2006). A New Calcineurin Inhibitor, Pimecrolimus, Inhibits the Growth of Malassezia spp.. Antimicrob. Agents Chemother. 50: 2897-2898 [Full Text]